Latest Issue
Get instant access to latest e-book

LATEST NEWSRead more...

11

Dec 2019

Bloom Science Collaborates with Cedars-Sinai Medical Center to Expand Microbiome Research and Discovery into Brain Cancer

Bloom Science a biopharmaceutical company developing microbiomederived therapeutics in multiple neurological conditions and oncology today announced the launch of a research agreement with CedarsSinai Medical Center The collaboration will focus on advancing the understanding of the microbiome in a P...

11

Dec 2019

Engitix and Morphic Enter Research Collaboration to Identify ECM-Related Targets in Fibrostenotic Inflammatory Bowel Disease (IBD)

Engitix Ltd Engitix a biotechnology company developing a portfolio of programmes in fibrosis and solid tumours using its proprietary human extracellular matrix ECM platform and Morphic Therapeutic Morphic a biopharmaceutical company developing oral integrin therapies today announce that they have en...

10

Dec 2019

Samyang Biopharm USA, Inc. and Talix Therapeutics NV Announce Global Strategic Collaboration to Advance Novel Immuno-Oncology Therapeutic

Samyang Biopharm USA Inc a global biotech subsidiary of the Samyang Pharmaceuticals Corp announced today that the company has entered into a research collaboration with the exclusive option to a worldwide licensing agreement with Talix Therapeutics NV Financial terms of the agreement were not disclo...

10

Dec 2019

Gemini Therapeutics and Avitide Enter Into Exclusive License Agreement

Avitide Inc the industry leader in the discovery and development of custom affinity purification resins announces that it has entered into an exclusive license agreement to support the development of one of Gemini Therapeutics therapeutic programs

09

Dec 2019

Janssen to Acquire Investigational Bermekimab from XBiotech

Janssen Biotech Inc a Janssen Pharmaceutical Company of Johnson Johnson announced today that it has entered a definitive agreement to acquire all rights to the investigational compound bermekimab from XBiotech Inc Bermekimab is an antiILalpha monoclonal antibody mAb in Phase development for the tr...

09

Dec 2019

GE Healthcare Life Sciences pairs up with Advanced Solutions Life Sciences to create new opportunities for regenerative tissue manufacturing

GE Healthcare Life Sciences and Advanced Solutions Life Sciences ASLS will enter into a strategic RD and distribution partnership that sets out to personalize tissue regeneration The integration of IN Cell Analyzer and BioAssemblyBot systems technologies will embed cellularlevel assessments into the...

06

Dec 2019

MaxCyte and KSQ Therapeutics Announce Development and Commercialization Agreement to Enable the Advancement of KSQ's Adoptive Cell Therapy Programs

MaxCyte the global cellbased therapies and life sciences company and KSQ Therapeutics a biotechnology company using its proprietary CRISPRomics discovery platform to achieve higher probabilities of success in drug development announced today that the companies have entered into a new development and...

06

Dec 2019

Zionexa Has Signed an Exclusive Agreement With PETNET Solutions Inc. for Manufacturing and Distribution

Zionexa a radiopharmaceutical company specialized in the development and commercialization of invivo biomarkers for use in guiding targeted therapies in oncology and PETNET Solutions Inc a Siemens Healthineers company specializing in the manufacturing and distribution of positron emission tomography...

05

Dec 2019

Gatehouse Bio collaborates with AstraZeneca to accelerate new drug discovery

Gatehouse Bio a pioneer in nextgeneration therapeutics is collaborating with AstraZeneca a global scienceled biopharmaceutical company to explore the identification of new targets for respiratory and cardiovascular diseases using Gatehouse Bios Artificial Intelligence AIpowered platform

press releasesRead more...

11

Dec 2019

Zealand Pharma partner Beta Bionics receives FDA Breakthrough Device Designation for the iLet™ Bionic Pancreas System

Zealand Pharma AS a Copenhagenbased biotechnology company focused on the discovery and development of innovative peptidebased medicines announces that partner Beta Bionics Inc has received Breakthrough Device designation from the US Food and Drug Administration FDA for its iLet Bionic Pancreas Syst...

11

Dec 2019

Dermira Receives Fast Track Designation from FDA for Lebrikizumab for the Treatment of Atopic Dermatitis

Dermira Inc a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated new therapies to the millions of patients living with chronic skin conditions today announced that the US Food and Drug Administration FDA has granted Fast Track design...

10

Dec 2019

Vetter's occupational health management excels again in employee wellness initiatives

According to studies an evergreater number of staff members are complaining about increasing mental stress Nevertheless according to a recent survey among staff members commissioned by LinkedIn percent of employers do not offer any preventive actions for stress symptoms such as tension or sleep dis...

10

Dec 2019

MetP Pharma Receives US Patent for Drug Therapy of Demyelinating and Neuroinflammatory Diseases such as Multiple Sclerosis

MetP Pharma AG today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office USPTO for its patent entitled Treatment of Demyelinating Diseases US Appl No Valid until the patent addresses a method to treat demyelinating diseases such as multiple scler...

10

Dec 2019

QuVa Pharma® Launches Cardioplegia Offering through a Compounding and Distribution Agreement with Hibernation Therapeutics for Adenocaine™ Solution

QuVa Pharma Inc today announced it has signed a production and distribution agreement with Hibernation Therapeutics for its patented cardioplegia solution Adenocaine the combination of Adenosine Lidocaine and Magnesium Sulfate that is used to intentionally stop the heart from beating during cardiac...

09

Dec 2019

Sangamo and Pfizer Announce Updated Phase 1/2 Results Showing Sustained Increased Factor VIII Activity Through 44 Weeks Following SB-525 Gene Therapy Treatment

Sangamo Therapeutics Inc a genomic medicine company and Pfizer Inc NYSE PFE today announced updated followup results from the Phase Alta study evaluating investigational SB gene therapy in patients with severe hemophilia A The data showed that SB was generally well tolerated and demonstrated sustai...

06

Dec 2019

MedPharm, the leader in topical and transdermal drug delivery, has moved into its newly expanded facility in Durham, North Carolina

The M expansion has tripled the facilitys footprint to approximately sq ft significantly expanding capacity and supporting MedPharms continued commitment to the topical and transdermal market

06

Dec 2019

Galectin Therapeutics Plans Adaptively Designed Phase 3 NASH-RX Clinical Trial in NASH Cirrhosis

Galectin Therapeutics Inc the leading developer of therapeutics that target galectin proteins recently presented its current plans for an Adaptively Designed Phase clinical trial NASHRX of its lead compound belapectin GRMD in the treatment of patients with nonalcoholic steatohepatitis NASH cirrhosi...

06

Dec 2019

Alector Announces FDA Fast Track Designation Granted to AL001 for the Treatment of Patients with Frontotemporal Dementia

Alector Inc a clinical stage biotechnology company pioneering immunoneurology today announced that the US Food and Drug Administration FDA has granted Fast Track designation for its investigational therapeutic AL for the treatment of patients with frontotemporal dementia FTD carrying specific geneti...

EventsRead more...

11 - 13

Dec 2019

Drug Delivery to the Lungs 2019

Edinburgh International Conference Centre

11 - 12

Dec 2019

12 - 13

Dec 2019

14th Biosimilars Congregation 2019

Kohinoor Continental Hotel

28 - 29

Dec 2019

Nursing Care and Patient Safety

GSE Academy
The President Hotel Cape Town

13 - 15

Jan 2020

Biotech Showcase 2020

EBD Group / Demy-Colton
Hilton San Francisco Union Square

15 - 17

Jan 2020

Otorhinolaryngology Audiology

InterContinental Dubai Festival City

20 - 21

Jan 2020

Disruptive Technologies In Pharma 2020

Holiday Inn Kensington Forum

20 - 21

Jan 2020

Annual Pharmaceutical Microbiology Conference

SMi Group
Copthorne Tara Hotel London Kensington

Advertisements

TOP ARTICLES

KNOWLEDGE BANK

  • Interviews

    Merck

    Staff Engineer, Manufacturing Science and Technology, South East Asia

    Karen Chan is a process engineer at Merck Pte Ltd Chan has six years of experience in the biopharmaceutical industry and two years of experience in research development She provides technical support in areas such as process development troubleshoot...
  • Articles

    A Concise Treatise on Hard and Soft Nanomaterials for Drug Delivery

    Most of the conventional free drugs suffer from high side effects poor adsorption poor solubility high drug dosing minimum efficiency uncontrolled and nonspecific delivery with high cytotoxicity which limit their uses With respect to the chemotherapeutic drugs concern is more because most of the anticancer drugs are highly toxic for the healthy cells and damage the he...

EDITORIAL SECTION

  • STRATEGY

    REDUCTION OF HEALTH COSTS

    Since autumn the first package of costcutting measures in Switzerlands healthcare system is being reviewed One of the measures is the socalled refere...